Report Categories
View AllRecent Articles
View All
SLNO Soleno Therapeutics tops Q4 2025 EPS estimates by 103 percent shares edge 021 percent lower today
DORM Dorman reports minor Q4 2025 EPS miss shares edge higher as investors shrug off the small shortfall
What IT spending PLDT Inc PHI Drifts Higher 20260501
What Social SCPQ auditor changes mean for investors SCPQ Latest Quarter Earnings Social has no EPS or revenue data amid growth push